Your browser doesn't support javascript.
loading
Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33).
Musacchio, Lucia; Salutari, Vanda; Pignata, Sandro; Braicu, Elena; Cibula, David; Colombo, Nicoletta; Frenel, Jean Sebastien; Zagouri, Flora; Carbone, Vittoria; Ghizzoni, Viola; Giolitto, Serena; Giudice, Elena; Perri, Maria Teresa; Ricci, Caterina; Scambia, Giovanni; Lorusso, Domenica.
Afiliação
  • Musacchio L; Department of Women and Child Health, Division of Gynaecologic Oncology, Policlinico Universitario Fondazione Agostino Gemelli, IRCCS, Rome, Lazio, Italy.
  • Salutari V; Department of Women and Child Health, Division of Gynaecologic Oncology, Policlinico Universitario Fondazione Agostino Gemelli, IRCCS, Rome, Lazio, Italy.
  • Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Braicu E; Department of Gynaecologic Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Cibula D; Department of Obstetrics and Gynaecology, General University Hospital, Prague, Czech Republic.
  • Colombo N; Gynecologic Oncology Program; European Institute of Oncology, IRCCS, University of Milan-Bicocca, Milan, Italy.
  • Frenel JS; Department of Medical Oncology, Institut de Cancerologie de l'Oust site Renè Gauducheau, Saint Herblain, France.
  • Zagouri F; Oncology Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Carbone V; Department of Women and Child Health, Division of Gynaecologic Oncology, Policlinico Universitario Fondazione Agostino Gemelli, IRCCS, Rome, Lazio, Italy.
  • Ghizzoni V; Department of Women and Child Health, Division of Gynaecologic Oncology, Policlinico Universitario Fondazione Agostino Gemelli, IRCCS, Rome, Lazio, Italy.
  • Giolitto S; Department of Women and Child Health, Division of Gynaecologic Oncology, Policlinico Universitario Fondazione Agostino Gemelli, IRCCS, Rome, Lazio, Italy.
  • Giudice E; Department of Women and Child Health, Division of Gynaecologic Oncology, Policlinico Universitario Fondazione Agostino Gemelli, IRCCS, Rome, Lazio, Italy.
  • Perri MT; Department of Women and Child Health, Division of Gynaecologic Oncology, Policlinico Universitario Fondazione Agostino Gemelli, IRCCS, Rome, Lazio, Italy.
  • Ricci C; Department of Women and Child Health, Division of Gynaecologic Oncology, Policlinico Universitario Fondazione Agostino Gemelli, IRCCS, Rome, Lazio, Italy.
  • Scambia G; Department of Women and Child Health, Division of Gynaecologic Oncology, Policlinico Universitario Fondazione Agostino Gemelli, IRCCS, Rome, Lazio, Italy.
  • Lorusso D; Department of Life Science and Public Health, Catholic University of Sacred Heart, Largo Agostino Gemelli, Rome, Italy.
Int J Gynecol Cancer ; 31(10): 1369-1373, 2021 10.
Article em En | MEDLINE | ID: mdl-34607820
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Piperidinas / Anticorpos Monoclonais Humanizados / Inibidores de Poli(ADP-Ribose) Polimerases / Inibidores de Checkpoint Imunológico / Indazóis Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Int J Gynecol Cancer Assunto da revista: GINECOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Piperidinas / Anticorpos Monoclonais Humanizados / Inibidores de Poli(ADP-Ribose) Polimerases / Inibidores de Checkpoint Imunológico / Indazóis Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Int J Gynecol Cancer Assunto da revista: GINECOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido